1884. Clinical Outcomes Among Patients with Drug-Resistant Tuberculosis Receiving Bedaquiline or Delamanid Containing Regimens

BACKGROUND: Bedaquiline and delamanid are new and much-needed treatment options for drug-resistant tuberculosis (TB); however, there are limited data guiding their use and no direct comparison of the two drugs. We thus sought to compare the clinical outcomes of patients with drug-resistant tuberculo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kempker, Russell R, Mikiashvili, Lali, Zhao, Yuan, Benkeser, David, Barbakadze, Ketino, Bablishvili, Nino, Peloquin, Charles, Blumberg, Henry, Kipiani, Maia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808986/
http://dx.doi.org/10.1093/ofid/ofz359.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808986/
http://dx.doi.org/10.1093/ofid/ofz359.114

Ejemplares similares